Physiologically relevant human tissue models for infectious diseases

Drug Discovery Today

Volumn 21, Issue 9, 2016, Pages 1540-1552

  Mills, Melody ^a   Estes, Mary K ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; COMMUNICABLE DISEASE; HUMAN; TISSUE ENGINEERING;

ANIMALS; COMMUNICABLE DISEASES; HUMANS; MODELS, BIOLOGICAL; TISSUE ENGINEERING;

EID: 84979529743     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.06.020     Document Type: Review

References (75)

1. 1 Seok, J., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 3507–3512.
2. 2 Warren, H.S., et al. Mice are not men. Proc. Natl. Acad. Sci. U. S. A., 112, 2015, E345.
3. 3 Bolker, J., Model organisms: there's more to life than rats and flies. Nature 491 (2012), 31–33.
4. 4 Martic-Kehl, M.I., et al. Can animal data predict human outcome? Problems and pitfalls of translational animal research. Eur. J. Nucl. Med. Mol. Imaging 39 (2012), 1492–1496.
5. 5 Langer, R., Vacanti, J.P., Tissue engineering. Science 260 (1993), 920–926.
6. 6 Birkness, K.A., et al. A tissue culture bilayer model to study the passage of Neisseria meningitidis. Infect. Immun. 63 (1995), 402–409.
7. 7 Kerneis, S., et al. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277 (1997), 949–952.
8. 8 Nickerson, C.A., et al. Three-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar Typhimurium pathogenesis. Infect. Immun. 69 (2001), 7106–7120.
9. 9 Dedhia, P.H., et al. Organoid models of human gastrointestinal development and disease. Gastroenterology 150 (2016), 1098–1112.
10. 10 Stelzner, M., et al. A nomenclature for intestinal in vitro cultures. Am. J. Physiol. Gastrointest. Liver Physiol. 302 (2012), G1359–G1363.
11. 11 Wikswo, J.P., The relevance and potential roles of microphysiological systems in biology and medicine. Exp. Biol. Med. 239 (2014), 1061–1072.
12. 12 Ramanan, V., et al. New methods in tissue engineering: improved models for viral infection. Annu. Rev. Virol. 1 (2014), 475–499.
13. 13 Lancaster, M.A., Knoblich, J.A., Organogenesis in a dish: modeling development and disease using organoid technologies. Science, 345, 2014, 1247125.
14. 14 Chwalek, K., et al. In vitro bioengineered model of cortical brain tissue. Nat. Protoc. 10 (2015), 1362–1373.
15. 15 Tang-Schomer, M.D., et al. Bioengineered functional brain-like cortical tissue. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 13811–13816.
16. 16 Lancaster, M.A., et al. Cerebral organoids model human brain development and microcephaly. Nature 501 (2013), 373–379.
17. 17 Lancaster, M.A., Knoblich, J.A., Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9 (2014), 2329–2340.
18. 18 Dang, J., et al. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell, 2016, 10.1016/j.stem.2016.04.014.
19. 19 Garcez, P.P., et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352 (2016), 816–818.
20. 20 Qian, X., et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165 (2016), 1238–1254.
21. 21 Brown, J.A., et al. Recreating blood–brain barrier physiology and structure on chip: a novel neurovascular microfluidic bioreactor. Biomicrofluidics, 9, 2015, 054124.
22. 22 Alcendor, D.J., et al. Neurovascular unit on a chip: implications for translational applications. Stem Cell Res. Ther., 4(Suppl. 1), 2013, 18.
23. 23 Leslie, J.L., Young, V.B., A whole new ball game: stem cell-derived epithelia in the study of host–microbe interactions. Anaerobe 37 (2016), 25–28.
24. 24 Wells, J.M., Regenerative medicine in 2015: generating and regenerating the digestive system. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 65–66.
25. 25 Sato, T., Clevers, H., Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340 (2013), 1190–1194.
26. 26 Zachos, N.C., et al. Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J. Biol. Chem. 291 (2016), 3759–3766.
27. 27 Sinagoga, K.L., Wells, J.M., Generating human intestinal tissues from pluripotent stem cells to study development and disease. EMBO J. 34 (2015), 1149–1163.
28. 28 Sato, T., Clevers, H., SnapShot: growing organoids from stem cells. Cell, 161, 2015, e1701 1700-1700.
29. 29 McCracken, K.W., et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516 (2014), 400–404.
30. 30 Bartfeld, S., et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology, 148, 2015, e126 126-136.
31. 31 Bartfeld, S., Clevers, H., Organoids as model for infectious diseases: culture of human and murine stomach organoids and microinjection of Helicobacter pylori. J. Vis. Exp., 2015, 10.3791/53359.
32. 32 Schlaermann, P., et al. A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro. Gut 65 (2016), 202–213.
33. 33 Huang, J.Y., et al. Chemodetection and destruction of host urea allows Helicobacter pylori to locate the epithelium. Cell Host Microbe 18 (2015), 147–156.
34. 34 Bertaux-Skeirik, N., Co-culture of gastric organoids and immortalized stomach mesenchymal cells. Methods Mol. Biol. 1422 (2016), 23–31.
35. 35 Ferrero, R.L., Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol. Immunol. 42 (2005), 879–885.
36. 36 Bartfeld, S., et al. High-throughput and single-cell imaging of NF-kappaB oscillations using monoclonal cell lines. BMC Cell Biol., 11, 2010, 21.
37. 37 Fischer, W., et al. Systematic mutagenesis of the Helicobacter pylori Cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42 (2001), 1337–1348.
38. 38 VanDussen, K.L., et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64 (2015), 911–920.
39. 39 Chen, Y., et al. Robust bioengineered 3D functional human intestinal epithelium. Sci. Rep., 5, 2015, 13708.
40. 40 Saxena, K., et al. Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology. J. Virol. 90 (2015), 43–56.
41. 41 In, J., et al. Enterohemorrhagic reduce mucus and intermicrovillar bridges in human stem cell-derived colonoids. Cell. Mol. Gastroenterol. Hepatol. 2 (2016), 48–62 e43.
42. 42 Tyska, M.J., Brush border destruction by enterohemorrhagic Escherichia coli (EHEC): new insights from organoid culture. Cell Mol. Gastroenterol. Hepatol. 2 (2016), 7–8.
43. 43 Foulke-Abel, J., et al. Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology 150 (2016), 638–649 e638.
44. 44 Middendorp, S., et al. Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells 32 (2014), 1083–1091.
45. 45 van de Wetering, M., et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161 (2015), 933–945.
46. 46 Ingber, D.E., Reverse engineering human pathophysiology with organs-on-chips. Cell 164 (2016), 1105–1109.
47. 47 Kim, H.J., et al. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E7–E15.
48. 48 Hagbom, M., et al. Towards a human rotavirus disease model. Curr. Opin. Virol. 2 (2012), 408–418.
49. 49 Finkbeiner, S.R., et al. Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio 3 (2012), e00159–00112.
50. 50 Yin, Y., et al. Modeling rotavirus infection and antiviral therapy using primary intestinal organoids. Antiviral Res. 123 (2015), 120–131.
51. 51 Kuhlmann, F.M., et al. Blood group O-dependent cellular responses to cholera toxin: parallel clinical and epidemiological links to severe cholera. Am. J. Trop. Med. Hyg., 2016, 16–0161.
52. 52 Engevik, M.A., et al. Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile. Am. J. Physiol. Gastrointest. Liver Physiol. 308 (2015), G497–509.
53. 53 Engevik, M.A., et al. Human Clostridium difficile infection: altered mucus production and composition. Am. J. Physiol. Gastrointest. Liver Physiol. 308 (2015), G510–524.
54. 54 Leslie, J.L., et al. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect. Immun. 83 (2015), 138–145.
55. 55 Forbester, J.L., et al. Interaction of Salmonella enterica serovar Typhimurium with intestinal organoids derived from human induced pluripotent stem cells. Infect. Immun. 83 (2015), 2926–2934.
56. 56 Lindemans, C.A., et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528 (2015), 560–564.
57. 57 Madan, B., et al. Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene 35 (2016), 2197–2207.
58. 58 DesRochers, T.M., et al. Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue. Infect. Immun. 83 (2015), 28–38.
59. 59 Little, M.H., Growing kidney tissue from stem cells: how far from “party trick” to medical application?. Cell Stem Cell 18 (2016), 695–698.
60. 60 Kelly, E.J., et al. Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system. Stem Cell Res. Ther., 4(Suppl. 1), 2013, 17.
61. 61 Petropolis, D.B., et al. A new human 3D-liver model unravels the role of galectins in liver infection by the parasite Entamoeba histolytica. PLoS Pathog., 10, 2014, e1004381.
62. 62 Petropolis, D.B., et al. Human liver infection in a dish: easy-to-build 3D liver models for studying microbial infection. PLoS One, 11, 2016, e0148667.
63. 63 March, S., et al. Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens. Nat. Protoc. 10 (2015), 2027–2053.
64. 64 Ng, S., et al. Human iPSC-derived hepatocyte-like cells support Plasmodium liver-stage infection in vitro. Stem Cell Rep. 4 (2015), 348–359.
65. 65 Shlomai, A., et al. Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 12193–12198.
66. 66 Ploss, A., et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 3141–3145.
67. 67 Ogawa, S., et al. Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 140 (2013), 3285–3296.
68. 68 Huch, M., et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160 (2015), 299–312.
69. 69 Braian, C., et al. A 3D human lung tissue model for functional studies on Mycobacterium tuberculosis infection. J. Vis. Exp., 2015, 10.3791/53084.
70. 70 Mairpady Shambat, S., et al. Modelling staphylococcal pneumonia in a human 3D lung tissue model system delineates toxin-mediated pathology. Dis. Model. Mech. 8 (2015), 1413–1425.
71. 71 Sundstrom, K.B., et al. Andes hantavirus-infection of a 3D human lung tissue model reveals a late peak in progeny virus production followed by increased levels of proinflammatory cytokines and VEGF-A. PLoS One, 11, 2016, e0149354.
72. 72 Nguyen Hoang, A.T., et al. Technical advance: live-imaging analysis of human dendritic cell migrating behavior under the influence of immune-stimulating reagents in an organotypic model of lung. J. Leukoc. Biol. 96 (2014), 481–489.
73. 73 Hogk, I., et al. 3D-tissue model for herpes simplex virus-1 infections. Methods Mol. Biol. 1064 (2013), 239–251.
74. 74 Siemens, N., et al. Increased cytotoxicity and streptolysin O activity in group G streptococcal strains causing invasive tissue infections. Sci. Rep., 5, 2015, 16945.
75. 75 Fabre, K.M., et al. Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue. Exp. Biol. Med. 239 (2014), 1073–1077.